Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients

Trial N/A Unknown June 6, 2016

Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson Disease

Trial Phase 2 Unknown June 2, 2016

Virtual Reality Effects on Functional Capacity and Quality of Life of People With Parkinson's Disease

Trial N/A Completed May 31, 2016

A Randomized Controlled Pilot Trial Comparing Irish Set Dancing to Usual Care for People With Parkinson's Disease

Trial N/A Completed May 31, 2016

How Does STN-DBS Influence Emotional Conflict Decision in Parkinson's Disease: a EEG Study

Trial N/A Completed May 31, 2016

A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients

Trial Phase 1 Completed May 22, 2016

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Trial Phase 4 Completed May 19, 2016

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa

Trial Phase 1 Completed May 18, 2016

Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures

Trial N/A Unknown May 18, 2016

Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease

Trial Phase 4 Unknown May 17, 2016

Safety, Tolerability, Pharmacokinetics (Including Food Interaction), and Pharmacodynamics of BIA 3-202

Trial Phase 1 Completed May 15, 2016

Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites

Trial Phase 1 Completed May 12, 2016

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

Trial Phase 1 Completed May 12, 2016

High-intensity Exercise and Fall Prevention Boot Camp for Parkinson's Disease

Trial Phase 2 Completed May 11, 2016

Resistance Versus Balance Training in Parkinson's Disease

Trial N/A Completed May 11, 2016

A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease

Trial Phase 1 Completed May 5, 2016

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)

Trial Phase 1 Completed May 4, 2016

Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202

Trial Phase 1 Completed May 4, 2016

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)

Trial Phase 1 Completed May 4, 2016

Mapping Mood in the Subthalamic Nucleus in Parkinson's Disease (PD)

Trial N/A Completed May 3, 2016